Speaker


Jérôme Van Biervliet | Managing Director, VIB Innovation & Business, VIB, Belgium

Dr. Van Biervliet has 20 yrs cross-disciplinary experience in the medical, business and biotech environments. Prior to his position as Managing Director in the general management of VIB: 
• He trained as a veterinary internal medicine specialist at Cornell University, 
• Was accredited by the American College of Veterinary Internal medicine and 
• Continued with a PhD at VIB finishing with a land-mark paper in Science. 
• After his clinical and research training, Dr. Van Biervliet started as a consultant at Bain & Company, advising especially in private equity transactions. 

Over the last 10 years, he has been in various roles in the VIB Innovation and Business office of VIB. 
• As the Head of Business Development, Dr. Van Biervliet is responsible for the BD team driving all industry collaborations, licensing of VIB assets and strategic collaborations. 
• He was the founder and Head of VIB Discovery Sciences, an internal drug discovery unit at VIB with a team of industry-trained scientists creating a portfolio of innovative projects. 

Dr. Van Biervliet is currently Managing Director for VIB as an institute in a tandem with his colleague Christine Durinx and holds end-responsibility for all of the Innovation & Business activities. 



VIB

VIB is a leading life sciences research institute based in Belgium, renowned for its work in medical sciences, plant biology, microbiology, artificial intelligence and biotechnology. VIB's mission is to push the boundaries of scientific discovery, transform it into disruptive biotech innovations and support the growth of the life sciences ecosystem in Flanders (Belgium). VIB is a partnership with Ghent University, Hasselt University, KU Leuven, University of Antwerp, and Vrije Universiteit Brussel.VIB drives the translation of research discoveries into innovative products and technologies for patients, consumers and society. It does so by launching new spin-offs, licensing intellectual property to companies, engaging in dynamic partnerships and fostering talent development. VIB has created 39 spin-offs in the healthcare and agrifood sectors, attracting over €1.8 billion in equity investment and has partnered intensely with industry, generating over €350 million in income. VIB’s research has led to dozens of innovative products brought to market for medical, agriculture, and food applications, with many more in development. Seven of its spin-off companies have reached the clinical stage.
Learn more at www.vib.be

Powered by:
Hyphen Projects   

Let's connect:           
Book a ticket
FAQ
Contact Us
Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
          
 
 

                                    

Keep me informed Download our event app


© Copyright 2023 by Hyphen Projects